GB9702135D0 - Nucleoside analogues - Google Patents

Nucleoside analogues

Info

Publication number
GB9702135D0
GB9702135D0 GBGB9702135.6A GB9702135A GB9702135D0 GB 9702135 D0 GB9702135 D0 GB 9702135D0 GB 9702135 A GB9702135 A GB 9702135A GB 9702135 D0 GB9702135 D0 GB 9702135D0
Authority
GB
United Kingdom
Prior art keywords
nucleoside analogues
nucleoside
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB9702135.6A
Other versions
GB2309968A (en
GB2309968B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Amersham International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602025.0A external-priority patent/GB9602025D0/en
Application filed by Amersham International PLC filed Critical Amersham International PLC
Priority to GB9702135A priority Critical patent/GB2309968B/en
Publication of GB9702135D0 publication Critical patent/GB9702135D0/en
Publication of GB2309968A publication Critical patent/GB2309968A/en
Application granted granted Critical
Publication of GB2309968B publication Critical patent/GB2309968B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Saccharide Compounds (AREA)
GB9702135A 1996-02-01 1997-02-03 Nucleoside analogues Expired - Fee Related GB2309968B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9702135A GB2309968B (en) 1996-02-01 1997-02-03 Nucleoside analogues

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602025.0A GB9602025D0 (en) 1996-02-01 1996-02-01 Nucleoside analogues
GB9702135A GB2309968B (en) 1996-02-01 1997-02-03 Nucleoside analogues

Publications (3)

Publication Number Publication Date
GB9702135D0 true GB9702135D0 (en) 1997-03-26
GB2309968A GB2309968A (en) 1997-08-13
GB2309968B GB2309968B (en) 2000-08-09

Family

ID=26308573

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9702135A Expired - Fee Related GB2309968B (en) 1996-02-01 1997-02-03 Nucleoside analogues

Country Status (1)

Country Link
GB (1) GB2309968B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235301B1 (en) * 1985-09-09 1992-07-22 Teijin Limited Pyridopyrimidine nucleotide derivatives
WO1993005175A1 (en) * 1991-09-11 1993-03-18 Medical Research Council Improvements in oligonucleotide primers and probes
DE4343126A1 (en) * 1993-12-17 1995-06-22 Hoechst Ag Solid phase synthesis of oligoribonucleotides

Also Published As

Publication number Publication date
GB2309968A (en) 1997-08-13
GB2309968B (en) 2000-08-09

Similar Documents

Publication Publication Date Title
GB9602028D0 (en) Nucleoside analogues
HU9700926D0 (en) Vitamine d3 analogues
EP0996458A4 (en) Sandramycin analogs
GB9715267D0 (en) Stethescope structure
GB9725415D0 (en) Advance arrangement
IL143867A0 (en) Antiviral nucleoside analogues
GB9512670D0 (en) Camptothecin analogues
GB9707849D0 (en) Structure
GB9608180D0 (en) Phosphate analogues
GB2309969B (en) Nucleoside analogues
GB2325203B (en) Rotating-wing aircraft
ZA975565B (en) Antiviral combinations
GB2309968B (en) Nucleoside analogues
GB9719804D0 (en) Bulkhead
ZA987267B (en) Nucleosides
GB9602124D0 (en) Degenerate nucleoside analogues
GB9409904D0 (en) Imidazopyrimidine nucleoside analogues
IL137390A0 (en) Nucleosides
GB9508479D0 (en) Imidazopyrimidine nucleoside analogues
GB9703121D0 (en) Advance arrangement
GB2327188B (en) Bulkhead
GB9222203D0 (en) Nucleoside analogues
ZA975564B (en) Antiviral combinations
HU0002453D0 (en) Novel nucleosides
GB9719883D0 (en) Antiviral combinations

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20040203